Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis

NCT ID: NCT06108648

Last Updated: 2025-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-07

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if lavender essential oil chest wraps relieve cough in infants with bronchiolitis compared to standard care. Furthermore, the researchers will evaluate if breathing difficulties, nighttime awakening and impact on parents will be improved by the lavender oil chest wraps. Infants will be randomized to receive standard care with the addition of lavender oil chest wraps or to receive standard care alone. The study will take place in two locations in Switzerland, at the Geneva University Hospital and the Fribourg Cantonal Hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiolitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients are randomized to receive standard care with additional lavender essential oil chest wrap during two nights of hospitalization or standard care alone.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lavender oil

Lavender chest wrap:

Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth. Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest. Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.

Group Type EXPERIMENTAL

Lavender essential oil 10%, diluted in 90% olive oil

Intervention Type DRUG

Lavender chest wrap:

Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth.

Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest.

Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.

Control

Standard care: supportive measures according to national standards.

Group Type ACTIVE_COMPARATOR

Control

Intervention Type OTHER

Standard care according to national standards.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lavender essential oil 10%, diluted in 90% olive oil

Lavender chest wrap:

Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth.

Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest.

Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.

Intervention Type DRUG

Control

Standard care according to national standards.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Bronchiolitis: clinical diagnosis based on the combination of respiratory distress (tachypnea, grunting, nasal flaring, retractions, and/or need for supplementary oxygen) and fine crackles sometimes accompanied by wheezing on auscultation.
* Hospitalization.
* Written informed consent.

Exclusion Criteria

* Patients with underlying diseases that impact respiratory or heart function (congenital heart disease, congenital malformation of the lung or airway system and severe chronic lung disease).
* More than 3 episodes of bronchiolitis.
* Critically ill infants who have an immediate need for intensive care unit (ICU) admission.
* Respiratory deterioration needing Continuous positive airway pressure (CPAP) or transfer to ICU during study enrollment.
* Atopic dermatitis, eczema or other skin lesions (particularly on the chest).
* Oncologic disease.
* Premature infants with mild bronchopulmonary dysplasia will not be excluded.
Maximum Eligible Age

11 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Geneva

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fabiola Stollar

Attending Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Klara Posfay-Barbe, MD, PhD

Role: STUDY_DIRECTOR

Children's' Hospital, University Hospital of Geneva, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland

Fribourg, , Switzerland

Site Status RECRUITING

Children's' Hospital, University Hospital of Geneva, Switzerland

Geneva, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fabiola Stollar, MD, PhD

Role: CONTACT

+41795534380

Tido von Schoen-Angerer, MD, MPH

Role: CONTACT

+41766159263

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Benedikt Huber, MD

Role: primary

+4126426711

Fabiola Stollar, MD, PhD

Role: primary

+41795534380

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-01116

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Home Oxygen Therapy in Bronchiolitis
NCT01216553 UNKNOWN PHASE4
Isotonic Saline for Children With Bronchiolitis
NCT05902702 NOT_YET_RECRUITING NA
Hypertonic Saline for Acute Bronchiolitis
NCT01247064 COMPLETED PHASE4